More People Turning to Over-the-Counter Birth Control Pill, Opill, Study Says

Follow Drugslib on

By I. Edwards HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 19, 2025.

via HealthDay

TUESDAY, Aug. 19, 2025 — Two years after U.S. approval of the first over-the-counter (OTC) birth control pill, new research shows many people who face barriers to medical care are turning to it.

The study, published Monday in JAMA Network Open, included data from 986 people ages 15 to 45 across 44 states. All had obtained the pill — known as Opill — either online or from a pharmacy.

Researchers found many switched from less effective birth control methods or from using no contraception at all.

There was a 31.8 percentage point increase in use among people who had previously used no birth control, and a 41 percentage point increase among those who had relied on methods like condoms or emergency contraception.

Opill, made by drug company Perrigo, is a progestin-only pill that can be bought without a prescription. When the U.S. Food and Drug Administration (FDA) approved it in 2023, it said the move could help lower barriers to access.

At that time, the FDA noted that nearly half of the 6.1 million pregnancies in the U.S. each year are unintended, CBS News reported.

“This is one of the first studies to show that over-the-counter birth control pills are reaching the very people they’re meant to help — those who face the greatest barriers to care,” said lead study author Dr. Maria Rodriguez, a professor of obstetrics and gynecology at Oregon Health & Science University in Portland.

The study found that people using the OTC pill were more often uninsured, younger (15 to 20 years of age), and living in rural areas.

The top reason people gave for choosing the OTC pill was that it did not require a doctor’s appointment. Others said they did not have a regular physician.

“At a time when pregnancy is becoming even more dangerous in the United States — especially for people of color, those with low incomes and those living in rural communities — our findings underscore that OTC contraception is a powerful tool for reproductive autonomy,” Rodriguez said in a news release.

An outside expert who reviewed the findings agreed.

Dr. Jessica Shepherd is a board-certified OB/GYN and chief medical officer of the online health company Hers.

"While greater access to contraception without prescriptions can be life-changing for women with limited resources, it also highlights how deeply the repercussions of unplanned pregnancies still ripple through health care systems and communities," she told CBS News.

"Unplanned pregnancies often result in higher maternal and infant health risks, financial strain and long-term socioeconomic challenges-consequences that weigh most heavily on women who already face barriers to care," Shepherd added.

Sources

  • CBS News, Aug. 18, 2025
  • EurekAlert!, news release, Aug. 18, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-08-20 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords